Amanote Research
Register
Sign In
Why First-Line Nivolumab Is No Better Than Chemo
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nd2017-004
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
August 4, 2017
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Dolev-Yao Is No Better Than Machiavelli
When No Law Is Better Than a Good Law
Review of Finance
Accounting
Economics
Econometrics
Finance
Acoustic Prepulse Inhibition: One Ear Is Better Than Two, but Why and When?
Psychophysiology
Developmental
Cognitive Psychology
Neuropsychology
Educational Psychology
Cognitive Neuroscience
Endocrine
Developmental Neuroscience
Physiological Psychology
Autonomic Systems
Neurology
Neuroscience
Biological Psychiatry
Physiology
Experimental
Why Biodiesel Is Environmentally Better Than Traditional, Fossil-Based Diesel: An LCA Approach
Environmental and Climate Technologies
Renewable Energy
the Environment
Sustainability
Environmental Science
Red Clover Is No Better Than Placebo for Hot Flushes
BMJ
Is Something Better Than Nothing?
Canadian Journal of Emergency Medicine
Emergency Medicine
Why Do Female Expatriates “Fit‐in” Better Than Males?
Cross Cultural Management: An International Journal
The Emergence of Adjacency Pairs: No Evidence Is Better Than Negative Evidence
When Two Is Better Than One
BioTechniques
Biochemistry
Biotechnology
Genetics
Molecular Biology